Infection prevention for immunocompromised patients: A cross-translational multicentric survey of current organization in France

•In France, access to infection prevention advice for immunocompromised patients is suboptimal.•Only 30% of the physicians interviewed reported on-site access to dedicated consultations.•Most were aware of nationwide guidelines for vaccination of immunocompromised patients.•Guidelines covering all fields of infection prevention would be more than welcome. To evaluate current organization of infection prevention for immunocompromised patients (ICP) at a countrywide level. Nationwide cross-sectional multicenter study based on an online survey disseminated in 2022 to physicians invested with preventive healthcare missions. A total of 341 physicians (96% graduates, 32% infectious disease specialists), participated in the survey, with a median age of 40 [35–51] years. On-site access to infection prevention consultations for ICP was reported by 30%, dedicated pre-travel consultations for ICPs by 29%, consultations for infection prevention in solid organ transplant candidates by 16% and return-to-work consultations for ICPs by 6%. Most participants (73%) were aware of nationwide vaccination guidelines for ICP, while 50% felt comfortable using them. Tools for infection prevention advice and ICP vaccination had been developed by 10%, while 89% would have appreciated access to tools developed by others. Infection prevention for ICPs remains neglected. Guidelines covering all fields of prevention for ICPs would be more than welcome.